Visalytics
Visalytics
approved EB-2 (NIW)

Postdoctoral Research Fellow

Ethnomedicine · Nigeria · 2023-02-27

Processing Time
74 days
Decision Date
2023-02-27
Location
South Africa
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to identify natural product drug candidates to develop therapeutics for the management of degenerative diseases such as cancer, diabetes mellitus, and HIV/AIDS. The work focuses on reducing the prevalence of these conditions through molecular biology-related DNA quantification and sequencing of indigenous medicinal plants.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses major medical concerns like diabetes and antibiotic resistance, which are identified as serious threats by the CDC.

2 Well-positioned to Advance the Endeavor Met

The petitioner has 8 years of research experience, a significant publication record of 33 articles, and has developed profiles for 23 species of medicinal plants.

3 Waiver of Job Offer and Labor Certification Met

Based on the petitioner's record of success and the broad implications of his work for U.S. public health, the labor certification requirement was waived.

Why This Petition Was Approved

The petition was approved based on 33 peer-reviewed journal articles and 6 book chapters which garnered 438 citations. The petitioner also demonstrated his influence through 10 peer reviews for authoritative journals and his service on editorial boards, satisfying the Dhanasar prongs for national importance and being well-positioned.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Postdoctoral Researcher

Pharmaceuticals · Vietnam

WeGreened EB-2 (NIW) approved
278 days 2025-01-11
The petitioner proposes to identify and analyze novel bioactive compounds isolated from natural sources with distinct chemical diversity. This work aims to accelerate the development of new pharmaceuticals for chronic diseases that currently lack adequate treatments, such as diabetes, cardiovascular disease, and osteoporosis.
View Case

Associate Professor

Pharmaceuticals · Pakistan

WeGreened EB-2 (NIW) approved
487 days 2025-04-15
The petitioner proposes to design natural compound-based therapeutics using computer-aided drug discovery to treat Type 1 diabetes and neurological disorders. This work focuses on developing non-synthetic therapeutic options for inflammation-related disorders, chronic pain, and systemic conditions using bioactive compounds from traditional medicinal plants. The endeavor aims to improve patient outcomes and address significant public health concerns in the United States.
View Case

Postdoctoral Researcher

Biotechnology · India

WeGreened EB-2 (NIW) approved
Tennessee 184 days 2022-10-04
The petitioner proposes to continue his research on the isolation and characterization of naturally sourced bioactive pharmacological compounds. This work focuses on developing new preventative and curative therapies for disorders such as diabetes mellitus, diabetic gastroparesis, and anxiety disorders.
View Case

Others

Pharmaceuticals · South Korea

WeGreened EB-2 (NIW) approved
54 days 2025-03-24
The petitioner proposes to continue her research in pharmaceutical science by integrating advanced technologies and computational approaches to develop novel drug candidates. Her work focuses on improving drug delivery systems to create more effective, affordable, and stable medications for chronic diseases including cancer, diabetes, hypertension, and neurodegenerative diseases.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Research and Development cases More cases from Nigeria

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-02-27.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 74 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Nigeria All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist